P2RX7 and pancreatic ductal adenocarcinoma: Similarly, we demonstrated increased G1-phase arrest and apoptosis which inhibited cell viability upon blockade of CAMP. CAMP promoted pancreatic ductal adenocarcinoma by activating cancer stem cell properties via a P2X7-dependent manner [57].